Controlling crystalline phase of TiO 2 thin films to evaluate its biocompatibility

K. J. Ramos-Corella, M. Sotelo-Lerma, A. A. Gil-Salido, J. L. Rubio-Pino, O. Auciello, M. A. Quevedo-López*

*Autor correspondiente de este trabajo

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

39 Citas (Scopus)


This paper describes studies performed to understand the biocompatibility of TiO 2 thin films with controlled crystalline phases using human pigment epithelium cells (ARPE-19). TiO 2 films were deposited by radio frequency magnetron sputtering using different gas pressure, oxygen partial pressure and magnetron power. Thermal annealing was used to control the microstructure and crystalline phase of the resulting films. Results show that films deposited at low power (75 and 100 W) developed anatase phase and as power increases (>125 W), a mixture of rutile and anatase is observed. For films deposited at higher power (>150 W), only rutile phase was obtained. These results indicate that plasma power is a critical parameter to control TiO 2 crystalline phase. Finally, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay showed that there is no significative difference in cell proliferation among TiO 2 crystalline phases and indicates that the biocompatibility is mostly defined by the surface chemistry of the films.

Idioma originalInglés
Páginas (desde-hasta)455-462
Número de páginas8
PublicaciónMaterials Technology
EstadoPublicada - 8 feb. 2019

Nota bibliográfica

Publisher Copyright:
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.


Profundice en los temas de investigación de 'Controlling crystalline phase of TiO 2 thin films to evaluate its biocompatibility'. En conjunto forman una huella única.

Citar esto